|
Aug 1
|
India's GlaxoSmithKline Pharma posts first revenue drop in over two years
|
|
Aug 1
|
Stocks Extend Losses on Tariffs, Swiss Franc Drops: Markets Wrap
|
|
Aug 1
|
Analysts Have Made A Financial Statement On GSK plc's (LON:GSK) Interim Report
|
|
Aug 1
|
The 'cheapest' stocks on FTSE 100 as UK blue-chip index trades at record high
|
|
Jul 31
|
What Trump's Big Pharma CEO letters mean for drug pricing power
|
|
Jul 31
|
Company News for Jul 31, 2025
|
|
Jul 31
|
Chicken Pox Market Analysis and Forecast 2025-2035 | Varicella Vaccine Demand Soars as Global Health Initiatives Expand
|
|
Jul 30
|
FTSE 100 ends flat ahead of likely US rate hold
|
|
Jul 30
|
GSK Beats on Q2 Earnings & Sales, Stock Gains on '25 Outlook Raise
|
|
Jul 30
|
GSK Lifts Outlook As Specialty Medicines, Vaccines Fuel Growth
|
|
Jul 30
|
GSK reports improved outlook despite US drug tariffs
|
|
Jul 30
|
GSK’s speciality medicines soar while generals drop, Q2 results reveal
|
|
Jul 30
|
GSK (GSK) Q2 Earnings and Revenues Beat Estimates
|
|
Jul 30
|
Glaxo: Q2 Earnings Snapshot
|
|
Jul 30
|
Cancer Vaccine Market Research Service Featuring the Top 5 Developers and Pipeline Activities - OncoTherapy Science, Inovio, BioNTech, Theravectys, and GlaxoSmithKline
|
|
Jul 30
|
GSK Upbeat on Guidance After Specialty Medicines Boost Sales
|
|
Jul 28
|
Astrazeneca, Other US-Listed Pharma Companies Seen Insulated From New EU Tariff Deal, Barclays Says
|
|
Jul 28
|
Synthetic rescue: Insmed explores a new frontier in genetic therapeutics
|
|
Jul 28
|
Hengrui Pharma and GSK enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology
|
|
Jul 25
|
Stocks to watch next week: Microsoft, Apple, Shell, AstraZeneca and HSBC
|